Regulatory Submission Templates for Elemental Impurities, Genotoxic Impurities, and Nitrosamine Impurities of Pharmaceutical Drug Substances

A BSTRACT Objective: Impurities are unanticipated chemical entities that have the potential to coexist with active pharmaceutical ingredients, posing an unexpected risk to their purity and overall quality. It has the potential to cause significant harm to human health, particularly if they have carcinogenic or mutagenic properties. Regulatory authorities mandate the submission of impurity risk assessments reports during dossier submission for key impurities such as heavy metals, nitrosamine and genotoxic impurities. Methods: The research article provides the techniques and strategies for impurity risk assessment in a flow chart format, based on the principles of the International Council for Harmonization (ICH) Q9 quality risk management. The methodology encompassed tailoring and furnishing distinct formats to address Elemental Impurities, Genotoxic Impurities, and Nitrosamine Impurities, aligning with the fundamental tenets of data submission outlined in accordance with the guidelines on quality risk management. Results: The specific formats were designed and provided for Elemental impurities, Genotoxic impurities, and Nitrosamine impurities as per the base principle of data submission. As a result, tailored formats were established and supplied to address Elemental Impurities, Genotoxic Impurities, and Nitrosamine Impurities. Conclusion: Hence, this research article effectively offers a transparent and precise methodology for identifying and managing impurity risks, employing risk assessment formats crafted in alignment with regulatory directives and practical insights, ensuring comprehensive mitigation strategies for Elemental Impurities, Genotoxic Impurities, and Nitrosamine Impurities of Pharmaceutical drug substances.